Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.
Blandine TramuntSarra SmatiSandrine CoudolMatthieu WargnyMatthieu PichelinBéatrice GuyomarchAbdallah Al-SalamehCoralie AmadouSara BarraudEdith BigotLyse BordierSophie BorotMuriel BourgeonOlivier BourronSybil CharrièreNicolas ChevalierEmmanuel CossonBruno FèveAnna Flaus-FurmaniukPierre FontaineAmandine GaliootCéline Gonfroy-LeymarieBruno GuerciSandrine LablancheJean-Daniel LalauEtienne LargerAdèle LasbleizBruno LaviolleMichel MarreMarion MunchLouis PotierGaëtan PrevostEric RenardYves ReznikDominique Seret-BéguéPaul SibiliaPhilippe ThuillierBruno VergèsJean-François GautierSamy HadjadjBertrand CariouFranck Mauvais-JarvisPierre GourdyPublished in: European journal of endocrinology (2021)
In patients with diabetes admitted for COVID-19, female sex was associated with lower incidence of early severe outcomes, but did not influence the overall in-hospital mortality, suggesting that diabetes mitigates the female protection from COVID-19 severity. Sex-associated biological determinants may be useful to optimize COVID-19 prevention and management in women and men.